Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.33 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.33 |
| ▸ | CACNA1C | Q13936 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26013243 | 0.90 | LMNA (0.46) | LMNATRPA1PTGS1CACNA1C | |
| SCHEMBL25450505 | 0.85 | LMNA (0.48) | LMNATRPA1PTGS1CACNA1C | |
| SCHEMBL25885582 | 0.82 | NPC1 (0.33) | LMNA | |
| SCHEMBL25450348 | 0.82 | LMNA (0.46) | LMNATRPA1PTGS1CACNA1C | |
| SCHEMBL26014558 | 0.81 | LMNA (0.42) | LMNATRPA1PTGS1CACNA1C | |
| SCHEMBL26014475 | 0.80 | LMNA (0.41) | LMNATRPA1PTGS1CACNA1C | |
| SCHEMBL26013323 | 0.80 | LMNA (0.41) | LMNATRPA1PTGS1CACNA1C | |
| SCHEMBL26013287 | 0.80 | EDNRA (0.38) | — | |
| SCHEMBL25475617 | 0.79 | PDE3B (0.33) | — | |
| SCHEMBL25475615 | 0.78 | CYP1A2 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11713333-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2023-08-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11713333-B2 | Organometallic compound, organic light-emitting device including the same, and diagnostic composition including the organometallic compound | ORC3, LAGE3, ORMDL3 | LMNA 3940/4885TRPA1 546/4885PTGS1 3908/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.